
Journey Medical Corporation: shareholders and insiders
Price
$3.69
November 18, 2026Market cap $90M
What Ploutos Investor adds for Journey Medical
Part of Ploutos Investor, €9.99 a month
- The full history: 6 fiscal years, from 2020
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
Insiders and their shares
Purchases and sales by officers and directors from Nov 18, 2025 to Jul 2, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
–
nobody
From Nov 18, 2025 to Nov 18, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
No sales in the period.
No trades under these filters.
From the Form 4s insiders file with the SEC within two business days of each trade.
Insiders and their shares
Every buy and sale by DERM's officers and directors from 2022 up to November 17, 2025, 4 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
Fell to 5% or less (1)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- Vanguard Capital Management3.59%Jul 31, 202613G/A
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Citadel Advisors (Griffin)In the quarter-37%
- Millennium Mgmt (Englander)In the quarter+118%
- D.E. ShawIn the quarter
- Renaissance TechnologiesIn the quarter-0.3%
- AQR CapitalIn the quarter
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Citadel Advisors (Griffin) | 51.5K | -37% | $400.0K | 0.00% |
| Millennium Mgmt (Englander) | 239.7K | +118% | $1.6M | 0.00% |
| D.E. Shaw | 12.8K | $100.0K | 0.00% | |
| Renaissance Technologies | 228.9K | -0.3% | $1.6M | 0.00% |
| AQR Capital | – | – | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 12.2% of its shares outstanding were held short, -2.2% since the report before.
- Shares held short
- 2.99M
- 12.2%
- Since the report before3.06M on Sep 30, 2026
- -2.2%
- 16.6
- 180.2K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 99%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 81.4K
- Nov 15, 2023: Shares held short 44.6K
- Nov 30, 2023: Shares held short 220.1K
- Dec 15, 2023: Shares held short 174.2K
- Dec 29, 2023: Shares held short 54.6K
- Jan 12, 2024: Shares held short 48.7K
- Jan 31, 2024: Shares held short 70.7K
- Feb 15, 2024: Shares held short 60.3K
- Feb 29, 2024: Shares held short 64.4K
- Mar 15, 2024: Shares held short 79.2K
- Mar 28, 2024: Shares held short 148.1K
- Apr 15, 2024: Shares held short 235.5K
- Apr 30, 2024: Shares held short 283.3K
- May 15, 2024: Shares held short 280.1K
- May 31, 2024: Shares held short 287.8K
- Jun 14, 2024: Shares held short 286.0K
- Jun 28, 2024: Shares held short 353.2K
- Jul 15, 2024: Shares held short 325.6K
- Jul 31, 2024: Shares held short 161.0K
- Aug 15, 2024: Shares held short 127.5K
- Aug 30, 2024: Shares held short 92.0K
- Sep 13, 2024: Shares held short 79.4K
- Sep 30, 2024: Shares held short 87.7K
- Oct 15, 2024: Shares held short 76.7K
- Oct 31, 2024: Shares held short 60.7K
- Nov 15, 2024: Shares held short 66.2K
- Nov 29, 2024: Shares held short 76.7K
- Dec 13, 2024: Shares held short 66.9K
- Dec 31, 2024: Shares held short 76.8K
- Jan 15, 2025: Shares held short 78.7K
- Jan 31, 2025: Shares held short 83.8K
- Feb 14, 2025: Shares held short 94.1K
- Feb 28, 2025: Shares held short 113.4K
- Mar 14, 2025: Shares held short 117.3K
- Mar 31, 2025: Shares held short 150.1K
- Apr 15, 2025: Shares held short 252.1K
- Apr 30, 2025: Shares held short 332.4K
- May 15, 2025: Shares held short 316.0K
- May 30, 2025: Shares held short 393.7K
- Jun 13, 2025: Shares held short 549.6K
- Jun 30, 2025: Shares held short 984.2K
- Jul 15, 2025: Shares held short 1.11M
- Jul 31, 2025: Shares held short 1.21M
- Aug 15, 2025: Shares held short 1.45M
- Aug 29, 2025: Shares held short 1.40M
- Sep 15, 2025: Shares held short 1.51M
- Sep 30, 2025: Shares held short 1.58M
- Oct 15, 2025: Shares held short 1.77M
- Oct 31, 2025: Shares held short 2.07M
- Nov 14, 2025: Shares held short 2.36M
- Nov 28, 2025: Shares held short 2.39M
- Dec 15, 2025: Shares held short 2.43M
- Dec 31, 2025: Shares held short 2.44M
- Jan 15, 2026: Shares held short 2.48M
- Jan 30, 2026: Shares held short 2.56M
- Feb 13, 2026: Shares held short 2.57M
- Feb 27, 2026: Shares held short 2.54M
- Mar 13, 2026: Shares held short 2.63M
- Mar 31, 2026: Shares held short 3.46M
- Apr 15, 2026: Shares held short 3.72M
- Apr 30, 2026: Shares held short 3.67M
- May 15, 2026: Shares held short 3.47M
- May 29, 2026: Shares held short 3.51M
- Jun 15, 2026: Shares held short 3.52M
- Jun 30, 2026: Shares held short 2.99M
- Jul 15, 2026: Shares held short 3.05M
- Jul 31, 2026: Shares held short 2.87M
- Aug 14, 2026: Shares held short 2.92M
- Aug 31, 2026: Shares held short 2.96M
- Sep 15, 2026: Shares held short 2.93M
- Sep 30, 2026: Shares held short 3.06M
- Oct 15, 2026: Shares held short 2.99M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading44.1% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 44.1% of the shares in the reported trades were short sales, against 35.6% in the 14 before.
- Last 14 sessionsOct 29, 2026 – Nov 17, 2026
- 44.1%
- The 14 beforeOct 9, 2026 – Oct 28, 2026
- 35.6%
- Change
- +8.5 pts
- Short sales a dayon average, of 96.6K shares
- 42.6K
- More than atof 3,659 US-listed companies, same days
- 31%
- Median of alleight in ten from 34.6% to 63.7%
- 50.3%
- Short sales
- Oct 9, 2026: Short sales 40.5%
- Oct 12, 2026: Short sales 10.8%
- Oct 13, 2026: Short sales 20.6%
- Oct 14, 2026: Short sales 37.6%
- Oct 15, 2026: Short sales 32.3%
- Oct 16, 2026: Short sales 54.6%
- Oct 19, 2026: Short sales 18.9%
- Oct 20, 2026: Short sales 42.5%
- Oct 21, 2026: Short sales 45.1%
- Oct 22, 2026: Short sales 51.8%
- Oct 23, 2026: Short sales 63.3%
- Oct 26, 2026: Short sales 39.7%
- Oct 27, 2026: Short sales 28.9%
- Oct 28, 2026: Short sales 49.7%
- Oct 29, 2026: Short sales 46.9%
- Oct 30, 2026: Short sales 38.6%
- Nov 2, 2026: Short sales 48.5%
- Nov 3, 2026: Short sales 33.5%
- Nov 4, 2026: Short sales 47.7%
- Nov 5, 2026: Short sales 60.7%
- Nov 6, 2026: Short sales 68.5%
- Nov 9, 2026: Short sales 58.3%
- Nov 10, 2026: Short sales 38.8%
- Nov 11, 2026: Short sales 46.2%
- Nov 12, 2026: Short sales 61.4%
- Nov 13, 2026: Short sales 42.5%
- Nov 16, 2026: Short sales 32.6%
- Nov 17, 2026: Short sales 39.7%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Claude MaraouiPresident & CEODirectly2.35M
- Ramsey AlloushCOODirectly504.8K
- Lindsay A Md RosenwaldDirectorDirectly397.6K
- Justin Adam SmithDirectorDirectly231.6K
- Joseph BeneschCFODirectly203.6K
- Miranda Jayne ToledanoDirectorDirectly168.6K
- Neil HerskowitzDirectorDirectly168.6K
- Jeffrey PaleyDirectorDirectly70.7K
- Michael Cooper PearceDirectorDirectly67.2K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Claude MaraouiPresident & CEO | 2.35M | – | May 2, 2025 | Form 4 |
| Ramsey AlloushCOO | 504.8K | – | May 2, 2025 | Form 4 |
| Lindsay A Md RosenwaldDirector | 397.6K | – | Jun 25, 2026 | Form 4 |
| Justin Adam SmithDirector | 231.6K | – | Jul 1, 2026 | Form 4 |
| Joseph BeneschCFO | 203.6K | – | May 2, 2025 | Form 4 |
| Miranda Jayne ToledanoDirector | 168.6K | – | Jul 1, 2026 | Form 4 |
| Neil HerskowitzDirector | 168.6K | – | Jul 1, 2026 | Form 4 |
| Jeffrey PaleyDirector | 70.7K | – | Nov 28, 2023 | Form 4 |
| Michael Cooper PearceDirector | 67.2K | – | Jun 25, 2026 | Form 4 |
A lower bound: it counts only the 9 officers and directors with a market trade since Nov 19, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWCiShares Micro-Cap ETFWeight in the fund0.02%
- VXFVanguard Extended Market Index FundWeight in the fund0.00%
- VTIVanguard Total Stock Market Index FundWeight in the fund0.00%
| ETF | Weight in the fund | Holdings as of |
|---|---|---|
| IWCiShares Micro-Cap ETF | 0.02% | Jun 30, 2026 |
| VXFVanguard Extended Market Index Fund | 0.00% | Jun 30, 2026 |
| VTIVanguard Total Stock Market Index Fund | 0.00% | Jun 30, 2026 |
3 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 68
- Q4 2025: Managers 77
- Q1 2026: Managers 72
- Q2 2026: Managers 71
Institutional investors by quarter
The fund managers holding DERM, quarter by quarter, from Q4 2014 to Q2 2025, 36 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 71 managers held 10.66M shares, worth $75M. During the quarter 23 opened a position, 23 closed one, 19 added and 22 trimmed.
The largest holders, Q2 2026
- Wasatch AdvisorsIn the quarter+34%
- Tang Capital ManagementIn the quarter
- Vanguard Capital ManagementIn the quarter-38%
- Punch & Associates Investment ManagementIn the quarter
- Pale Fire Capital SEIn the quarter+9.7%
- Opaleye ManagementIn the quarter-64%
- Summit FinancialIn the quarter-8.7%
- Jane Street GroupIn the quarter
- Diametric CapitalIn the quarter+51%
- Ikarian CapitalIn the quarter
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Wasatch Advisors | 2.86M | +34% | $20M |
| Tang Capital Management | 1.61M | $11M | |
| Vanguard Capital Management | 675.2K | -38% | $4.8M |
| Punch & Associates Investment Management | 536.0K | $3.8M | |
| Pale Fire Capital SE | 528.6K | +9.7% | $3.7M |
| Opaleye Management | 350.0K | -64% | $2.5M |
| Summit Financial | 346.7K | -8.7% | $2.5M |
| Jane Street Group | 320.0K | $2.3M | |
| Diametric Capital | 295.7K | +51% | $2.1M |
| Ikarian Capital | 251.4K | $1.8M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Journey Medical's filings show?
Who buys and sells is one part of Journey Medical's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have DERM's insiders bought or sold?
From Jun 26, 2026 to Jul 2, 2026 Journey Medical's insiders reported no purchase or sale of shares on the market.
Which well-known managers hold DERM?
5 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $1.6M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.